Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




US Regulation Would Require Bar Codes on All Drugs

By HospiMedica staff writers
Posted on 24 Mar 2003
As part of a sweeping new three-part program to reduce medication errors and improve patient safety, the US Food and Drug Administration (FDA, Washington, DC, USA) has proposed a new regulation that would require bar codes on all prescription drugs.

The new regulation would apply to all over-the-counter drugs packaged for hospital use, vaccines, and blood and blood components. More...
At a minimum, the bar code would contain the drug's National Drug Code number, which identifies the drug, its strength, and its dosage form. The FDA is also considering whether to include lot number and expiration date. The agency estimates that the bar code rule will result in a 50% increase in the interception of medication errors at the dispensing and administration stages. In a study at a US Veterans Affairs Medical Center, 5.7 million doses of medication were administered to patients with no errors when a bar code scanning medication dispensing system was used.

A bar-coded identification bracelet will link patients to their computerized medical record. Before administering a drug, a healthcare worker would scan the patient's computerized record, then scan the drugs provided by the pharmacy for the patient. The computer compares the patient's medical record to the drug(s) being administered to ensure they match what is prescribed for the patient. If they do not, the computer sends an error message and the problem is investigated. The regulation is designed to prevent problems such as the wrong drug, the wrong dose, the wrong time to administer the drug, or a change in the patient's medication.

Along with this regulation, the FDA has proposed new rules governing the reporting of safety information. These were developed jointly with authorities in the pharmaceutical and biologic industry and regulatory authorities in the European Union, Canada, Switzerland, and Japan to improve the quality and consistency of safety information reporting. Other new rules would require expedited reporting of suspected adverse drug reactions (SADR) that are serious and unexpected, new safety findings from clinical studies, and improved data in all reporting.

These proposals are part of a new framework of FDA programs to identify and manage safety problems associated with regulated medical products, using modern information technology, partnerships with healthcare organizations, and more-effective communication tools. Automatic, real-time transmission of safety data from healthcare systems will be an important part of these programs.




Related Links:
FDA

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.